Literature DB >> 11071507

A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation.

M Yasuda1, K Yokoyama, T Nakayasu, Y Nishimura, M Matsui, T Yokoyama, K Miyoshi, C Tanaka.   

Abstract

The authors report a patient carrying a missense mutation in exon 10 of tau that causes a substitution at codon 301 (P301S). Although the patient shares the rapidly progressive frontotemporal dementia of the other reported pedigrees with P301S, the clinical phenotype is unique in that parkinsonism was a major symptom in the early stage and because behavioral symptoms with dementia became prominent 2 years after the onset of the disease. This study substantiates the notion that tau mutations at codon 301 can show various phenotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071507     DOI: 10.1212/wnl.55.8.1224

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Familial autosomal dominant cortico-basal degeneration with the P301S mutation in the tau gene: an example of phenotype variability.

Authors:  W Casseron; J P Azulay; E Guedj; J L Gastaut; J Pouget
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

Review 2.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

3.  Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.

Authors:  Termpanit Chalermpalanupap; Jason P Schroeder; Jacki M Rorabaugh; L Cameron Liles; James J Lah; Allan I Levey; David Weinshenker
Journal:  J Neurosci       Date:  2017-11-13       Impact factor: 6.167

4.  Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation.

Authors:  Y Baba; M C Baker; I Le Ber; A Brice; L Maeck; J Kohlhase; M Yasuda; G Stoppe; O Bugiani; A D Sperfeld; Y Tsuboi; R J Uitti; M J Farrer; B Ghetti; M L Hutton; Z K Wszolek
Journal:  J Neural Transm (Vienna)       Date:  2007-02-23       Impact factor: 3.575

5.  Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer's Disease.

Authors:  S Tok; H Maurin; C Delay; D Crauwels; N V Manyakov; W Van Der Elst; D Moechars; W H I M Drinkenburg
Journal:  Acta Neuropathol Commun       Date:  2022-06-23       Impact factor: 7.578

6.  Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease.

Authors:  S Tok; H Maurin; C Delay; D Crauwels; N V Manyakov; W Van Der Elst; D Moechars; W H I M Drinkenburg
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

Review 7.  Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

Authors:  Zbigniew K Wszolek; Yoshio Tsuboi; Bernardino Ghetti; Stuart Pickering-Brown; Yasuhiko Baba; William P Cheshire
Journal:  Orphanet J Rare Dis       Date:  2006-08-09       Impact factor: 4.123

8.  The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice.

Authors:  Jack Brelstaff; Bernardino Ossola; Jonas J Neher; Therése Klingstedt; K Peter R Nilsson; Michel Goedert; Maria Grazia Spillantini; Aviva M Tolkovsky
Journal:  Front Neurosci       Date:  2015-05-29       Impact factor: 4.677

Review 9.  Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.

Authors:  Carmen Gasca-Salas; Mario Masellis; Edwin Khoo; Binit B Shah; David Fisman; Anthony E Lang; Galit Kleiner-Fisman
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

10.  Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier.

Authors:  Peter Bentham; Roger T Staff; Bjoern O Schelter; Helen Shiells; Charles R Harrington; Claude M Wischik
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.